-

Thermo Fisher Scientific Introduces Next Generation TruNarc Handheld Narcotics Analyzers to Support Public Safety

Devices identify more than 1,200 substances such as fentanyl and methamphetamine in seconds while accurately differentiating other high-risk materials

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today introduced the Thermo Scientific™ TruNarc™ Delta and Tau Handheld Narcotics Analyzers* to help communities combat known and emerging narcotics and illicit substances. With touchless technology and an expanded chemical library, the user-friendly devices empower frontline law enforcement officials to identify more than 1,200 substances in the field, including stimulants, depressants, hallucinogens and analgesics – even at low concentrations or in mixtures – in seconds.**

As drug substances continue to evolve and become harder to identify, the on-device chemical library of the TruNarc analyzer is updated regularly to keep pace with new and emerging illicit drug threats.

Share

Drug overdoses, particularly due to the illicit use of opioids such as fentanyl and methamphetamines, claim the lives of more than 100,000 people in the United States alone each year. Law enforcement officials, in particular, face an increased risk of unintentional exposure and challenges with accurately identifying dangerous substances in the field. The TruNarc analyzers enable law enforcement officials to test substances they seize from a safe distance, helping them stop the flow of drugs across borders and keep narcotics off the streets.

“For nearly a decade, the first generation TruNarc analyzer has been an integral part of our operations and is essential in our fight against the drug epidemic,” said Brian Coen, drug unit detective at the Quincy Police Department in Massachusetts. “With so many emerging drugs entering our communities, it is imperative to know what we are dealing with right away. With rapid, on-the-spot identification, we can trigger the appropriate response – whether it’s making an arrest, leveraging results in criminal proceedings or directing people to relevant rehabilitation programs.”

Manufactured in Tewksbury, Mass., the new TruNarc analyzers build on the first generation with an updated industrial design, improved and modernized user interface, and performance enhancements that enable faster results. Automated record keeping generates documentation with complete scan data, including time-and-date stamps, to expedite prosecution and secure legal integrity. As drug substances continue to evolve and become harder to identify, the on-device chemical library of the TruNarc analyzer is updated regularly to keep pace with new and emerging illicit drug threats.

“Since we first introduced the TruNarc analyzer, we’ve earned the trust of law enforcement officials through reliable performance and proven results,” said Richard McCartney, president of chemical analysis at Thermo Fisher Scientific. “As the opioid crisis persists, there’s a clear need for enhanced tools that better support public safety. By building on our proven technology, we are equipping those in the field with lab-quality tools that are durable enough to be used in a variety of environments.”

Law enforcement agencies in all 50 states and in more than 50 countries have adopted the TruNarc analyzer since its introduction to the market in 2012. To learn more about the new TruNarc analyzers, please visit: www.thermofisher.com/trunarc

* The TruNarc Delta Narcotics Analyzer is designed for use within the United States. The TruNarc Tau Narcotics Analyzer is available globally. Both models offer the same trusted performance but are tailored to meet global export requirements.

** Low concentration mixtures may require additional preparation time and the use of a Type H2 test kit to analyze illicit compounds.

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Contacts

Media Contact Information:
Jesse Stivender, Thermo Fisher Scientific
510-299-4720
jesse.stivender@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

Thermo Fisher

NYSE:TMO
Details
Headquarters: Waltham, Massachusetts
CEO: Marc N. Casper
Employees: 100,000
Organization: PUB
Revenues: $40 Billion (2021)

Release Versions

Contacts

Media Contact Information:
Jesse Stivender, Thermo Fisher Scientific
510-299-4720
jesse.stivender@thermofisher.com

Jessika Parry, Greenough
419-266-4016
jparry@greenoughagency.com

More News From Thermo Fisher

Thermo Fisher Scientific Launches Multiskan™ Ease Absorbance Microplate Reader to Help Simplify Protein, Cell and Microbial Analysis

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific today announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, designed to support protein quantification, enzyme-linked immunosorbent assays (ELISAs), cell viability studies, microbial growth monitoring and other routine laboratory applications with simplified operation and dependable performance. Laboratories performing absorbance-based analysis are under increasing pressure to generate reliable data...

Thermo Fisher Scientific to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman and chief executive officer, will present at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, September 15, 2026 at 9:15 a.m. (ET).You can access the live webcast of the presentation via the Investors section of our website, www.thermofisher.com.About Thermo Fisher ScientificThermo Fisher Scientific Inc. is the world leade...

Thermo Fisher Scientific Introduces the Thermo Scientific™ EMPAD™ G2 Electron Detector to Advance Materials Research

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today introduced the Thermo Scientific™ EMPAD™ G2 detector, a new detector designed to help researchers see and understand materials in unprecedented detail. EMPAD G2 enables high-speed four-dimensional scanning transmission electron microscopy (4D STEM), an advanced form of electron microscopy that captures far more information about a material than a standard image, helping researchers better...
Back to Newsroom